Eurofins Scient (OTCMKTS:ERFSF) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Eurofins Scient (OTCMKTS:ERFSF) have received an average rating of “Hold” from the five analysts that are currently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company.

A number of equities research analysts have weighed in on the stock. Citigroup reiterated a “neutral” rating on shares of Eurofins Scient in a research note on Monday. BNP Paribas Exane upgraded shares of Eurofins Scient to an “outperform” rating in a research report on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Eurofins Scient in a research report on Wednesday, October 29th.

Eurofins Scient Trading Down 2.1%

Shares of ERFSF stock opened at $80.55 on Thursday. Eurofins Scient has a 12 month low of $48.55 and a 12 month high of $86.20. The stock has a 50 day moving average of $75.77 and a two-hundred day moving average of $74.58. The company has a current ratio of 1.26, a quick ratio of 1.19 and a debt-to-equity ratio of 0.77.

About Eurofins Scient

Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.

Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.